TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Primary central nervous system lymphoma (PCNSL) is an aggressive variant of diffuse large B-cell lymphoma (DLBCL) confined to the CNS. TP53 mutations (MUT-TP53) were investigated in the context of MIR34A/B/C- and DAPK promoter methylation status, and associated with clinical outcomes in PCNSL patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Munch-Petersen, Helga D., Asmar, Fazila, Dimopoulos, Konstantinos, Areškevičiūtė, Aušrinė, Brown, Peter, Girkov, Mia Seremet, Pedersen, Anja, Sjö, Lene D., Heegaard, Steffen, Broholm, Helle, Kristensen, Lasse S., Ralfkiaer, Elisabeth, Grønbæk, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840983/
https://www.ncbi.nlm.nih.gov/pubmed/27101868
http://dx.doi.org/10.1186/s40478-016-0307-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840983/
https://www.ncbi.nlm.nih.gov/pubmed/27101868
http://dx.doi.org/10.1186/s40478-016-0307-6

Ejemplares similares